Yandi Gao is a Principal Biologist at Eli Lilly. Before working at industry, She had eight years of research experience in muscular dystrophy and host immune responses at The Ohio State university. She received her Master's degree in Molecular Pharmaceutics from Loyola University Medical School in 2014.
Roland Herzog, Ph.D., is a Professor of Pediatrics, Riley Children's Foundation Professor of Immunology, and Director of the Gene and Cell Therapy Program. His research interests are in gene therapy and immune tolerance for hemophilia and in AAV vectors.
Weidong Xiao, Ph.D., is a Professor of Pediatrics and Grzegorz Nalepa Scholar for Molecular Therapy. He serves as Associate Director of the Gene and Cell Therapy Program at the Herman B Wells Center for Pediatric Research. Dr. Xiao obtained his Ph.D from UNC-Chapel Hill, where he started his research career on adeno-associated viral (AAV) vectors. He later held faculty positions at the University of Pennsylvania and Temple University before joining Indiana University. Dr. Xiao's research focuses on molecular virology, development of vectors for gene therapy, and treatment of hemophilia.
Renzhi Han, Ph.D., is a Professor of Pediatrics at Indiana University School of Medicine. His research primarily focuses on studying genetic myopathies and developing adeno-associated viral (AAV) vectors and non-viral approaches for lasting correction of human diseases, such as muscular dystrophy and cardiovascular diseases.
Copyright 2024 All Rights Reserved. Zhida Therapeutics INC
